These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16082023)

  • 21. Efficient process development of recombinant human granulocyte colony-stimulating factor (rh-GCSF) production in Escherichia coli.
    Babaeipour V; Khanchezar S; Mofid MR; Pesaran Hagi Abbas M
    Iran Biomed J; 2015; 19(2):102-10. PubMed ID: 25864815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new vector for heterologous gene expression in Escherichia coli with increased stability in the absence of antibiotic.
    Eguia FAP; Ramos HR; Kraschowetz S; Omote D; Ramos CRR; Ho PL; Carvalho E; Gonçalves VM
    Plasmid; 2018 Jun; 98():22-30. PubMed ID: 30193910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors that influence the extracellular expression of streptavidin in Escherichia coli using a bacteriocin release protein.
    Miksch G; Ryu S; Risse JM; Flaschel E
    Appl Microbiol Biotechnol; 2008 Nov; 81(2):319-26. PubMed ID: 18795286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of unglycosylated human caseinomacropeptide by engineering DAB Escherichia coli.
    Liu F; Liao L; Chen J
    J Agric Food Chem; 2008 Feb; 56(3):889-93. PubMed ID: 18189353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced biodegradation of toxic organophosphate compounds using recombinant Escherichia coli with sec pathway-driven periplasmic secretion of organophosphorus hydrolase.
    Kang DG; Choi SS; Cha HJ
    Biotechnol Prog; 2006; 22(2):406-10. PubMed ID: 16599554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A general approach for heterologous membrane protein expression in Escherichia coli: the uncoupling protein, UCP1, as an example.
    Shaw AZ; Miroux B
    Methods Mol Biol; 2003; 228():23-35. PubMed ID: 12824541
    [No Abstract]   [Full Text] [Related]  

  • 27. High-level expression of a recombinant fragment of human fibronectin containing the Cell I-Hep II-IIICS71 domain in Escherichia coli as a soluble protein.
    Li M; Feng Z; Zhang G; Li D
    Biotechnol Lett; 2006 Jul; 28(14):1141-6. PubMed ID: 16794767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput recovery of therapeutic proteins from the inclusion bodies of Escherichia coli: an overview.
    Panda AK
    Methods Mol Biol; 2005; 308():155-61. PubMed ID: 16082033
    [No Abstract]   [Full Text] [Related]  

  • 29. Periplasmic secretion of native ovalbumin without signal cleavage in Escherichia coli.
    Arii Y; Takahashi N; Hirose M
    Biosci Biotechnol Biochem; 2003 Feb; 67(2):368-71. PubMed ID: 12729000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on high-expression of soluble hbFGF in Escherichia coli].
    Sun J; Hong A; Zhang L; Sun F; Song Z
    Wei Sheng Wu Xue Bao; 2003 Aug; 43(4):448-52. PubMed ID: 16276918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving aquaporin Z expression in Escherichia coli by fusion partners and subsequent condition optimization.
    Lian J; Ding S; Cai J; Zhang D; Xu Z; Wang X
    Appl Microbiol Biotechnol; 2009 Mar; 82(3):463-70. PubMed ID: 19005651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant design and expression of human anti-rabies virus ScdsFv].
    Cai K; Wang H; Bao SZ; Shi J; Hou XJ
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):673-6. PubMed ID: 17944370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression, renaturation and simultaneous purification of recombinant human stem cell factor in Escherichia coli.
    Lili W; Chaozhan W; Xindu G
    Biotechnol Lett; 2006 Jul; 28(13):993-7. PubMed ID: 16786266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of efficient method for purified recombinant bovine granulocyte-macrophage colony-stimulating factor production with baculovirus-silkworm gene expression system.
    Nagaya H; Kanaya T; Tobita Y; Yokomizo Y; Inumaru S; Onodera T
    Biotechnol Lett; 2008 Jan; 30(1):41-5. PubMed ID: 17700995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for protein coexpression in Escherichia coli.
    Tolia NH; Joshua-Tor L
    Nat Methods; 2006 Jan; 3(1):55-64. PubMed ID: 16369554
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of folding factors in rescuing unstable heterologous lipase B to enhance its overexpression in the periplasm of Escherichia coli.
    Xu Y; Lewis D; Chou CP
    Appl Microbiol Biotechnol; 2008 Jul; 79(6):1035-44. PubMed ID: 18496685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level expression, purification, and characterization of non-tagged Aspergillus flavus urate oxidase in Escherichia coli.
    Li J; Chen Z; Hou L; Fan H; Weng S; Xu C; Ren J; Li B; Chen W
    Protein Expr Purif; 2006 Sep; 49(1):55-9. PubMed ID: 16545578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of recombinant human mutant granulocyte colony stimulating factor (Nartograstim) in Escherichia coli.
    Gomes FR; Maluenda AC; Tápias JO; Oliveira FL; Sá-Rocha LC; Carvalho E; Ho PL
    World J Microbiol Biotechnol; 2012 Jul; 28(7):2593-600. PubMed ID: 22806165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recombinant protein production in Escherichia coli].
    Nuc P; Nuc K
    Postepy Biochem; 2006; 52(4):448-56. PubMed ID: 17536514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.